Market Rally Aims for “Cloud Nine,” Bronfman'...

NYU Professor Aswath Damodaran joins to discuss why he's saying AI could be having its "bar mitzvah moment" right now. Then, National Cattlemen’s Beef Association CEO Colin Woodall discusses the trade group's opposition to President Trump's new plan to lower beef prices. Plus, Fo ...  Show more

Atlantic Council CEO Fred Kempe joins to discuss the latest development in the trade war between the U.S. and Canada with President Trump saying he will increase tariffs on Canadian cars and trucks next year. Then, Webull U.S. CEO Anthony Denier joins to discuss the recent crypto ...  Show more

Shares in Eli Lilly surged on Friday  after its experimental pill helped patients shed weight and control blood sugar about as well as Ozempic, an advance that could turbocharge what’s already one of the fastest growing markets in medicine. Shares of the drug’s originator Chugai ...  Show more

Stocks jumping to start the week, as investors hope President Trump may be softening his stance on tariffs. If you can believe the bounce, and the sectors seeing the biggest gains. Plus One pharma company looking to tip the scales in the weight loss drug space. What the CEO of ...

The Dow was down 942 points at its session lows in a September-style selloff to start the week and Jim Cramer is helping investors navigate the day’s volatility. Then, as pharmaceutical companies focus on COVID-19, Eli Lilly CEO Dave Ricks checks in to discuss the company's pr ...

Shares of Apple jumping to record highs just a day after falling flat on its new AI announcements. The turnaround for the tech titan, and what it means for the market. Plus The weight loss wars rage on… and we’re honing in on oral version of GLP-1’s. How one pharma stock is fa ...